Shai Biran

Head of Investor Relations @Spero Therapeutics

Brookline, MA, US

EMAILS

[email protected]

MOBILE NUMBERS

+91 *********19

Reveal Contact Details

Signup · Get unlimited contacts

WORK HISTORY

May 2024 — Present

Head of Investor Relations @Spero Therapeutics

View department →

Cambridge, MA, US

EDUCATION

2006 — 2008

Tel Aviv University

M.Sc., Biotechnology

2009 — 2014

Weizmann Institute of Science

Doctor of Philosophy (Ph.D.), Structural Biology

2003 — 2006

Tel Aviv University

B.Sc., Biology with emphasis on Biotechnology

SKILLS

BiochemistryMolecular BiologyProtein ChemistryIn VitroExperimentationIn VivoProtein PurificationStructural BiologyLife SciencesTissue CultureProtein ExpressionWestern BlottingHistologyTransfectionFluorescence MicroscopyMicroscopyCell BiologyMolecular CloningLifesciencesPcrCell CultureImmunoprecipitationImmunohistochemistryAnimal ModelsSds-PageElisaResearchScienceBiotechnologyDnaX-Ray CrystallographyComputational BiologyMicrosoft WordPowerpointMicrosoft Excel

ABOUT SHAI BIRAN

An experienced investor relations and corporate communications biotech executive with a Ph.D. in structural biology, I leverage my scientific background and industry experience to drive robust and intelligent investor relations engagement. I excel in crafting compelling narratives tailored for diverse audiences and am passionate about advancing health science discoveries into clinical applications for patients.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.